ALK c.3522C>G ;(p.F1174L)

Variant ID: 2-29443695-G-C

NM_004304.4(ALK):c.3522C>G;(p.F1174L)

This variant was identified in 534 publications

View GRCh38 version.




Publications:


Poster Presentation.

Experimental Animals
Publication Date: 2023

Variant appearance in text: ALK: F1174L
PubMed Link: 37316216
Variant Present in the following documents:
  • expanim-72-S104.pdf
View BVdb publication page



Sustained Improvement in the Management of Patients with Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocation: Where Are We Running?

Current Oncology (Toronto, Ont.)
Spitaleri, Gianluca G; Trillo Aliaga, Pamela P; Attili, Ilaria I; Del Signore, Ester E; Corvaja, Carla C; Corti, Chiara C; Crimini, Edoardo E; Passaro, Antonio A; de Marinis, Filippo F
Publication Date: 2023-05-16

Variant appearance in text: ALK: F1174L
PubMed Link: 37232842
Variant Present in the following documents:
  • Main text
  • curroncol-30-00384.pdf
View BVdb publication page



Refined high-content imaging-based phenotypic drug screening in zebrafish xenografts.

Npj Precision Oncology
Sturtzel, C C; Grissenberger, S S; Bozatzi, P P; Scheuringer, E E; Wenninger-Weinzierl, A A; Zajec, Z Z; Dernovšek, J J; Pascoal, S S; Gehl, V V; Kutsch, A A; Granig, A A; Rifatbegovic, F F; Carre, M M; Lang, A A; Valtingojer, I I; Moll, J J; Lötsch, D D; Erhart, F F; Widhalm, G G; Surdez, D D; Delattre, O O; André, N N; Stampfl, J J; Tomašič, T T; Taschner-Mandl, S S; Distel, M M
Publication Date: 2023-05-18

Variant appearance in text: ALK: F1174L
PubMed Link: 37202469
Variant Present in the following documents:
  • Main text
View BVdb publication page



EML4-ALK biology and drug resistance in Non-Small Cell Lung Cancer: a new phase of discoveries.

Molecular Oncology
Elshatlawy, Mariam M; Sampson, Josephina J; Clarke, Katy K; Bayliss, Richard R
Publication Date: 2023-05-07

Variant appearance in text: ALK: F1174L
PubMed Link: 37149843
Variant Present in the following documents:
  • Main text
  • MOL2-17-950.pdf
View BVdb publication page



Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastoma.

Nature Communications
Berko, Esther R ER; Witek, Gabriela M GM; Matkar, Smita S; Petrova, Zaritza O ZO; Wu, Megan A MA; Smith, Courtney M CM; Daniels, Alex A; Kalna, Joshua J; Kennedy, Annie A; Gostuski, Ivan I; Casey, Colleen C; Krytska, Kateryna K; Gerelus, Mark M; Pavlick, Dean D; Ghazarian, Susan S; Park, Julie R JR; Marachelian, Araz A; Maris, John M JM; Goldsmith, Kelly C KC; Radhakrishnan, Ravi R; Lemmon, Mark A MA; Mossé, Yaël P YP
Publication Date: 2023-05-05

Variant appearance in text: ALK: F1174L
PubMed Link: 37147298
Variant Present in the following documents:
  • Main text
  • 41467_2023_Article_38195.pdf
  • 41467_2023_38195_MOESM3_ESM.xlsx, sheet 2
  • 41467_2023_38195_MOESM3_ESM.xlsx, sheet 4
  • 41467_2023_38195_MOESM3_ESM.xlsx, sheet 1
View BVdb publication page



Circulating Cell-Free Tumor Deoxyribonucleic Acid Analysis as a Tool for the Diagnosis and Monitoring of Pediatric Solid Tumors.

Turkish Archives Of Pediatrics
Zaninović, Luca L; Bašković, Marko M; Katušić Bojanac, Ana A; Ježek, Davor D
Publication Date: 2023-05

Variant appearance in text: ALK: F1174L
PubMed Link: 37144257
Variant Present in the following documents:
  • Main text
  • tap-58-3-241.pdf
View BVdb publication page



TYRO3 promotes tumorigenesis and drug resistance in colorectal cancer by enhancing the epithelial-mesenchymal transition process.

Aging
Shao, Xinyu X; Sun, Yibin Y; Zhong, Kaiqiang K; Gu, Jinrong J; Yu, Yang Y; Hu, Tong T; Kuai, Xiaoyi X; Xing, Yechen Y
Publication Date: 2023-04-14

Variant appearance in text: ALK: F1174L
PubMed Link: 37116196
Variant Present in the following documents:
  • aging-15-204656.pdf
View BVdb publication page



Cuproptosis-related molecular subtypes direct T cell exhaustion phenotypes and therapeutic strategies for patients with lung adenocarcinoma.

Frontiers In Pharmacology
Zhu, Yi-Pan YP; Deng, Hui-Ting HT; Wang, Xiuyu X; Rahat, Michal A MA; Sun, Shupeng S; Zhang, Qiang-Zhe QZ
Publication Date: 2023

Variant appearance in text: ALK: F1174L
PubMed Link: 37113755
Variant Present in the following documents:
  • Main text
  • fphar-14-1146468.pdf
View BVdb publication page



Molecular Tumor Boards: The Next Step towards Precision Therapy in Cancer Care.

Hematology Reports
Liu, Angela A; Vicenzi, Paige P; Sharma, Ishna I; Orr, Kaci K; Teller, Christa C; Koentz, Micha M; Trinkman, Heidi H; Vallance, Kelly K; Ray, Anish A
Publication Date: 2023-04-04

Variant appearance in text: ALK: F1174L
PubMed Link: 37092519
Variant Present in the following documents:
  • Main text
  • hematolrep-15-00025.pdf
View BVdb publication page



Case report: Epithelioid inflammatory myofibroblastic sarcoma treated with an ALK TKI ensartinib.

Frontiers In Oncology
Li, Mengmeng M; Xing, Ruyue R; Huang, Jiuyan J; Shi, Chao C; Wei, Chunhua C; Wang, Huijuan H
Publication Date: 2023

Variant appearance in text: ALK: F1174l
PubMed Link: 37035183
Variant Present in the following documents:
  • fonc-13-1084456.pdf
View BVdb publication page



Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results.

Nature Medicine
Goldsmith, Kelly C KC; Park, Julie R JR; Kayser, Kimberly K; Malvar, Jemily J; Chi, Yueh-Yun YY; Groshen, Susan G SG; Villablanca, Judith G JG; Krytska, Kateryna K; Lai, Lillian M LM; Acharya, Patricia T PT; Goodarzian, Fariba F; Pawel, Bruce B; Shimada, Hiroyuki H; Ghazarian, Susan S; States, Lisa L; Marshall, Lynley L; Chesler, Louis L; Granger, Meaghan M; Desai, Ami V AV; Mody, Rajen R; Morgenstern, Daniel A DA; Shusterman, Suzanne S; Macy, Margaret E ME; Pinto, Navin N; Schleiermacher, Gudrun G; Vo, Kieuhoa K; Thurm, Holger C HC; Chen, Joseph J; Liyanage, Marlon M; Peltz, Gerson G; Matthay, Katherine K KK; Berko, Esther R ER; Maris, John M JM; Marachelian, Araz A; Mossé, Yael P YP
Publication Date: 2023-04-03

Variant appearance in text: ALK: F1174L
PubMed Link: 37012551
Variant Present in the following documents:
  • Main text
  • 41591_2023_Article_2297.pdf
  • 41591_2023_2297_MOESM1_ESM.pdf
View BVdb publication page



Plasma ctDNA increases tissue NGS-based detection of therapeutically targetable mutations in lung cancers.

Bmc Cancer
Xie, Jianjiang J; Yao, Weishen W; Chen, Lingxiu L; Zhu, Wenjun W; Liu, Qiang Q; Geng, Geng G; Fang, Jing J; Zhao, Yang Y; Xiao, Li L; Huang, Zhenhua Z; Zhao, Jing J
Publication Date: 2023-03-31

Variant appearance in text: ALK: Phe1174Leu
PubMed Link: 37004022
Variant Present in the following documents:
  • Main text
View BVdb publication page



Molecular Anatomy of the EML4-ALK Fusion Protein for the Development of Novel Anticancer Drugs.

International Journal Of Molecular Sciences
Cheon, So Yeong SY; Kwon, Sunghark S
Publication Date: 2023-03-18

Variant appearance in text: ALK: F1174L
PubMed Link: 36982897
Variant Present in the following documents:
  • Main text
  • ijms-24-05821.pdf
View BVdb publication page



Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome.

Nature Genetics
Körber, Verena V; Stainczyk, Sabine A SA; Kurilov, Roma R; Henrich, Kai-Oliver KO; Hero, Barbara B; Brors, Benedikt B; Westermann, Frank F; Höfer, Thomas T
Publication Date: 2023-03-27

Variant appearance in text: ALK: F1174L
PubMed Link: 36973454
Variant Present in the following documents:
  • 41588_2023_1332_MOESM4_ESM.xlsx, sheet 2
  • 41588_2023_1332_MOESM4_ESM.xlsx, sheet 7
View BVdb publication page



Genomics-Driven Precision Medicine in Pediatric Solid Tumors.

Cancers
Suthapot, Praewa P; Chiangjong, Wararat W; Chaiyawat, Parunya P; Choochuen, Pongsakorn P; Pruksakorn, Dumnoensun D; Sangkhathat, Surasak S; Hongeng, Suradej S; Anurathapan, Usanarat U; Chutipongtanate, Somchai S
Publication Date: 2023-02-23

Variant appearance in text: ALK: F1174L
PubMed Link: 36900212
Variant Present in the following documents:
  • cancers-15-01418.pdf
View BVdb publication page



Segmental chromosomal aberrations as the poor prognostic factor in children over 18 months with stage 3 neuroblastoma without MYCN amplification.

Frontiers In Oncology
Wieczorek, Aleksandra A; Szewczyk, Katarzyna K; Klekawka, Tomasz T; Stefanowicz, Joanna J; Ussowicz, Marek M; Drabik, Grazyna G; Pawinska-Wasikowska, Katarzyna K; Balwierz, Walentyna W
Publication Date: 2023

Variant appearance in text: ALK: Phe1174Leu
PubMed Link: 36865795
Variant Present in the following documents:
  • Main text
  • fonc-13-1134772.pdf
View BVdb publication page



Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer.

Cancer Discovery
Pradat, Yoann Y; Viot, Julien J; Yurchenko, Andrey A AA; Gunbin, Konstantin K; Cerbone, Luigi L; Deloger, Marc M; Grisay, Guillaume G; Verlingue, Loic L; Scott, Veronique V; Padioleau, Ismael I; Panunzi, Leonardo L; Michiels, Stefan S; Hollebecque, Antoine A; Jules-Clement, Gerome G; Mezquita, Laura L; Laine, Antoine A; Loriot, Yohann Y; Besse, Benjamin B; Friboulet, Luc L; Andre, Fabrice F; Cournede, Paul-Henry PH; Gautheret, Daniel D; Nikolaev, Sergey I SI
Publication Date: 2023-03-02

Variant appearance in text: ALK: F1174L
PubMed Link: 36862804
Variant Present in the following documents:
  • Main text
  • 1116.pdf
  • cd-22-0966_supplementary_tables_s1-s11_suppst1.xlsx, sheet 10
  • cd-22-0966_supplementary_tables_s1-s11_suppst1.xlsx, sheet 6
View BVdb publication page



Genomic ALK alterations in primary and relapsed neuroblastoma.

British Journal Of Cancer
Rosswog, Carolina C; Fassunke, Jana J; Ernst, Angela A; Schömig-Markiefka, Birgid B; Merkelbach-Bruse, Sabine S; Bartenhagen, Christoph C; Cartolano, Maria M; Ackermann, Sandra S; Theissen, Jessica J; Blattner-Johnson, Mirjam M; Jones, Barbara B; Schramm, Kathrin K; Altmüller, Janine J; Nürnberg, Peter P; Ortmann, Monika M; Berthold, Frank F; Peifer, Martin M; Büttner, Reinhard R; Westermann, Frank F; Schulte, Johannes H JH; Simon, Thorsten T; Hero, Barbara B; Fischer, Matthias M
Publication Date: 2023-02-17

Variant appearance in text: ALK: F1174L
PubMed Link: 36807339
Variant Present in the following documents:
  • Main text
  • 41416_2023_Article_2208.pdf
  • 41416_2023_2208_MOESM1_ESM.pdf
View BVdb publication page



Adaptive resistance to lorlatinib via EGFR signaling in ALK-rearranged lung cancer.

Npj Precision Oncology
Katayama, Yuki Y; Yamada, Tadaaki T; Tanimura, Keiko K; Tokuda, Shinsaku S; Morimoto, Kenji K; Hirai, Soichi S; Matsui, Yohei Y; Nakamura, Ryota R; Ishida, Masaki M; Kawachi, Hayato H; Yoneda, Kazue K; Hosoya, Kazutaka K; Tsuji, Takahiro T; Ozasa, Hiroaki H; Yoshimura, Akihiro A; Iwasaku, Masahiro M; Kim, Young Hak YH; Horinaka, Mano M; Sakai, Toshiyuki T; Utsumi, Takahiro T; Shiotsu, Shinsuke S; Takeda, Takayuki T; Katayama, Ryohei R; Takayama, Koichi K
Publication Date: 2023-01-26

Variant appearance in text: ALK: F1174L
PubMed Link: 36702855
Variant Present in the following documents:
  • Main text
  • 41698_2023_Article_350.pdf
View BVdb publication page



Targeted treatment of refractory primitive neuroectodermal tumor arising from an immature teratoma with crizotinib leading to a sustained response.

Clinical Case Reports
Snyder, Benjamin M BM; Lion, Alex H AH; Helvie, Amy E AE; Marshall, Mark S MS; Ferguson, Michael J MJ
Publication Date: 2023-01

Variant appearance in text: ALK: F1174L
PubMed Link: 36619485
Variant Present in the following documents:
  • CCR3-11-e6779.pdf
View BVdb publication page



Inhibition of PI3 kinase isoform p110α suppresses neuroblastoma growth and induces the reduction of Anaplastic Lymphoma Kinase.

Cell & Bioscience
Guo, Yue Y; Guo, Donghao D; Zhang, Shaoting S; Zhang, Yuan Y; He, Xiaoyan X; Jiang, Xiaohua X; Chan, Andrew Man-Lok AM; Zou, Lin L; Sun, Jianmin J; Zhao, Hui H
Publication Date: 2022-12-30

Variant appearance in text: ALK: F1174L
PubMed Link: 36585695
Variant Present in the following documents:
  • Main text
  • 13578_2022_Article_946.pdf
View BVdb publication page



Single-cell next-generation sequencing of circulating tumor cells in patients with neuroblastoma.

Cancer Science
Kojima, Masato M; Harada, Takanori T; Fukazawa, Takahiro T; Kurihara, Sho S; Touge, Ryo R; Saeki, Isamu I; Takahashi, Shinya S; Hiyama, Eiso E
Publication Date: 2022-12-26

Variant appearance in text: ALK: F1174L
PubMed Link: 36571449
Variant Present in the following documents:
  • Main text
  • CAS-114-1616.pdf
View BVdb publication page



Silibinin Overcomes EMT-Driven Lung Cancer Resistance to New-Generation ALK Inhibitors.

Cancers
Verdura, Sara S; Encinar, Jose Antonio JA; Teixidor, Eduard E; Segura-Carretero, Antonio A; Micol, Vicente V; Cuyàs, Elisabet E; Bosch-Barrera, Joaquim J; Menendez, Javier A JA
Publication Date: 2022-12-11

Variant appearance in text: ALK: F1174L
PubMed Link: 36551587
Variant Present in the following documents:
  • cancers-14-06101.pdf
View BVdb publication page



SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma.

Journal Of Experimental & Clinical Cancer Research : Cr
Tan, Kezhe K; Mo, Jialin J; Li, Meng M; Dong, Yu Y; Han, Yujie Y; Sun, Xi X; Ma, Yingxuan Y; Zhu, Kai K; Wu, Wei W; Lu, Li L; Liu, Jiangbin J; Zhao, Kewen K; Zhang, Lei L; Tang, Yujie Y; Lv, Zhibao Z
Publication Date: 2022-12-20

Variant appearance in text: ALK: F1174L
PubMed Link: 36539767
Variant Present in the following documents:
  • 13046_2022_Article_2563.pdf
View BVdb publication page



Primary resistance to first- and second-generation ALK inhibitors in a non-small cell lung cancer patient with coexisting ALK rearrangement and an ALK F1174L-cis-S1189C de novo mutation: A case report.

Frontiers In Pharmacology
Zhao, Jiuzhou J; Li, Xiang X; Fan, Ruizhe R; Qin, Yaping Y; Wang, Zhizhong Z; Wang, Bo B; Li, Shaomei S; Fan, Jianfeng J; Wu, Xinxin X; Liu, Hongxia H; Guan, Yuping Y; Liang, Yinfeng Y; Zhang, Xiao X; Guo, Yongjun Y
Publication Date: 2022

Variant appearance in text: ALK: F1174L
PubMed Link: 36506539
Variant Present in the following documents:
  • Main text
  • fphar-13-1060460.pdf
View BVdb publication page



Applications and prospects of targeted therapy for neuroblastoma.

World Journal Of Pediatric Surgery
Wang, Jing J; Yao, Wei W; Li, Kai K
Publication Date: 2020

Variant appearance in text: ALK: F1174L
PubMed Link: 36474924
Variant Present in the following documents:
  • Main text
  • wjps-2020-000164.pdf
View BVdb publication page



Exosomes in Neuroblastoma Biology, Diagnosis, and Treatment.

Life (Basel, Switzerland)
Jahangiri, Leila L; Ishola, Tala T
Publication Date: 2022-10-27

Variant appearance in text: ALK: F1174L
PubMed Link: 36362869
Variant Present in the following documents:
  • Main text
  • life-12-01714.pdf
View BVdb publication page



Biochemical and structural basis for differential inhibitor sensitivity of EGFR with distinct exon 19 mutations.

Nature Communications
van Alderwerelt van Rosenburgh, Iris K IK; Lu, David M DM; Grant, Michael J MJ; Stayrook, Steven E SE; Phadke, Manali M; Walther, Zenta Z; Goldberg, Sarah B SB; Politi, Katerina K; Lemmon, Mark A MA; Ashtekar, Kumar D KD; Tsutsui, Yuko Y
Publication Date: 2022-11-10

Variant appearance in text: ALK: F1174L
PubMed Link: 36357385
Variant Present in the following documents:
  • Main text
  • 41467_2022_Article_34398.pdf
View BVdb publication page



Non-small-cell lung cancer: how to manage ALK-, ROS1- and NTRK-rearranged disease.

Drugs In Context
Marinelli, Daniele D; Siringo, Marco M; Metro, Giulio G; Ricciuti, Biagio B; Gelibter, Alain J AJ
Publication Date: 2022

Variant appearance in text: ALK: F1174L
PubMed Link: 36303600
Variant Present in the following documents:
  • Main text
  • dic-2022-3-1.pdf
View BVdb publication page



A comprehensive next generation sequencing tissue assay for Asian-prevalent cancers-Analytical validation and performance evaluation with clinical samples.

Frontiers In Molecular Biosciences
Ng, Cedric Chuan-Young CC; Lim, Sandy S; Lim, Abner Herbert AH; Md Nasir, Nur Diyana ND; Zhang, Jingxian J; Rajasegaran, Vikneswari V; Lee, Jing Yi JY; Kok, Jessica Sook Ting JST; Thike, Aye Aye AA; Lim, Johnathan Xiande JX; Weng, Ruifen R; Yee, Sidney S; Choudhury, Yukti Y; Chan, Jason Yongsheng JY; Tan, Puay Hoon PH; Tan, Min-Han MH; Teh, Bin Tean BT
Publication Date: 2022

Variant appearance in text: ALK: F1174L
PubMed Link: 36213130
Variant Present in the following documents:
  • DataSheet1.xlsx, sheet 11
View BVdb publication page



MHY4571, a novel diarylcyclohexanone derivative, exerts anti-cancer activity by regulating the PKA-cAMP-response element-binding protein pathway in squamous cell lung cancer.

Experimental Hematology & Oncology
Chung, Jae Heun JH; Choi, Ho Jung HJ; Kang, Yong Jung YJ; Kim, Yun Seong YS; Lee, Sang-Yull SY; Kwon, Ryuk Jun RJ; Jeong, Han-Sol HS; Park, Su-Jung SJ; Jeong, Yeongmu Y; Kang, Dongwan D; Ko, Jeongin J; Noh, SangGyun S; Chung, Hae Young HY; Moon, Hyung Ryong HR; Yoon, Seong Hoon SH
Publication Date: 2022-10-08

Variant appearance in text: ALK: F1174L
PubMed Link: 36209131
Variant Present in the following documents:
  • 40164_2022_324_MOESM2_ESM.xlsx, sheet 2
View BVdb publication page



Lorlatinib and compound mutations in ALK+ large-cell neuroendocrine lung carcinoma: a case report.

Cold Spring Harbor Molecular Case Studies
Wiedemann, Christiane C; Kazdal, Daniel D; Cvetkovic, Jelena J; Kunz, Julia J; Fisch, David D; Kirchner, Martina M; Kriegsmann, Mark M; Sültmann, Holger H; Heussel, Claus-Peter CP; Bischoff, Helge H; Thomas, Michael M; Stenzinger, Albrecht A; Christopoulos, Petros P
Publication Date: 2022-10

Variant appearance in text: ALK: F1174L
PubMed Link: 36207130
Variant Present in the following documents:
  • MCS006234Wie.pdf
View BVdb publication page



Liquid biopsy using ascitic fluid and pleural effusion supernatants for genomic profiling in gastrointestinal and lung cancers.

Bmc Cancer
Wu, Huita H; Ji, Haonan H; Yang, Wenhui W; Zhang, Min M; Guo, Yifang Y; Li, Bangkai B; Wang, Jiayin J; Chen, Rongrong R; Chen, Yuan Y; Wang, Xin X
Publication Date: 2022-09-27

Variant appearance in text: ALK: F1174L
PubMed Link: 36167530
Variant Present in the following documents:
  • 12885_2022_9922_MOESM5_ESM.xlsx, sheet 1
View BVdb publication page



Durable clinical response to ALK tyrosine kinase inhibitors in ALK-rearranged non-small cell lung cancer: a case report.

Translational Cancer Research
Hu, Han H; Dai, Hui H; Ding, Liren L
Publication Date: 2022-08

Variant appearance in text: ALK: F1174L
PubMed Link: 36093526
Variant Present in the following documents:
  • Main text
  • tcr-11-08-2967.pdf
View BVdb publication page



Loss of ALK hotspot mutations in relapsed neuroblastoma.

Genes, Chromosomes & Cancer
Allinson, Lisa M LM; Potts, Aaron A; Goodman, Angharad A; Bown, Nick N; Bashton, Matthew M; Thompson, Dean D; Basta, Nermine O NO; Gabriel, Alem S AS; McCorkindale, Michael M; Ng, Antony A; McNally, Richard J Q RJQ; Tweddle, Deborah A DA
Publication Date: 2022-12

Variant appearance in text: ALK: F1174L
PubMed Link: 36029175
Variant Present in the following documents:
  • Main text
  • GCC-61-747.pdf
View BVdb publication page



Fibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK-rearranged non-small cell lung cancer.

Cancer Science
Sakashita, Takuya T; Yanagitani, Noriko N; Koike, Sumie S; Low, Siew-Kee SK; Takagi, Satoshi S; Baba, Satoko S; Takeuchi, Kengo K; Nishio, Makoto M; Fujita, Naoya N; Katayama, Ryohei R
Publication Date: 2022-11

Variant appearance in text: ALK: F1174L
PubMed Link: 35950895
Variant Present in the following documents:
  • CAS-113-3888.pdf
View BVdb publication page



AACR Project GENIE: 100,000 Cases and Beyond.

Cancer Discovery
Pugh, Trevor J TJ; Bell, Jonathan L JL; Bruce, Jeff P JP; Doherty, Gary J GJ; Galvin, Matthew M; Green, Michelle F MF; Hunter-Zinck, Haley H; Kumari, Priti P; Lenoue-Newton, Michele L ML; Li, Marilyn M MM; Lindsay, James J; Mazor, Tali T; Ovalle, Andrea A; Sammut, Stephen-John SJ; Schultz, Nikolaus N; Yu, Thomas V TV; Sweeney, Shawn M SM; Bernard, Brady B; ,
Publication Date: 2022-09-02

Variant appearance in text: ALK: F1174L
PubMed Link: 35819403
Variant Present in the following documents:
  • cd-21-1547_supplementary_table_1_suppst1.xlsx, sheet 1
View BVdb publication page



Genomic Alterations Identification and Resistance Mechanisms Exploration of NSCLC With Central Nervous System Metastases Using Liquid Biopsy of Cerebrospinal Fluid: A Real-World Study.

Frontiers In Oncology
Shen, Fangfang F; Liang, Naixin N; Fan, Zaiwen Z; Zhao, Min M; Kang, Jing J; Wang, Xifang X; Hu, Qun Q; Mu, Yongping Y; Wang, Kai K; Yuan, Mingming M; Chen, Rongrong R; Guo, Wei W; Dong, Guilan G; Zhao, Jun J; Bai, Jun J
Publication Date: 2022

Variant appearance in text: ALK: 3522C>G; F1174L
PubMed Link: 35814426
Variant Present in the following documents:
  • DataSheet_1.xlsx, sheet 2
View BVdb publication page



The Change in Paradigm for NSCLC Patients with EML4-ALK Translocation.

International Journal Of Molecular Sciences
Bearz, Alessandra A; De Carlo, Elisa E; Del Conte, Alessandro A; Spina, Michele M; Da Ros, Valentina V; Bertoli, Elisa E; Revelant, Alberto A; Stanzione, Brigida B; Tirelli, Umberto U
Publication Date: 2022-06-30

Variant appearance in text: ALK: F1174L
PubMed Link: 35806325
Variant Present in the following documents:
  • ijms-23-07322.pdf
View BVdb publication page